Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-05-09
2009-02-17
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S325000
Reexamination Certificate
active
07491731
ABSTRACT:
A crystal structure of the cfms kinase domain, co-crystal structure with a bound small molecule, as well as methods of using the same in the discovery of cfms inhibitors and in the treatment of diseases mediated by inappropriate cfms activity.
REFERENCES:
Vippagunta et al., Crystalline Solids, Advanced Drug Delivery Reviews, 48, pp. 3-26, 2001.
West, Solid Solutions, Chapter 10, pp. 358 and 365, 1988.
Ulrich, Crystallization: 4. Crystal Characteristics, Kirk-Othmer Encyclopedia of Chemical Technology, Aug. 2002.
So et al., Application of Neural Works, J. Med. Chem. vol. 35, No. 17, pp. 3201-3207, 1992.
Alonso, G., Koegl, M., Mazurenko, N. and Courtneidge, S.A. (1995). Sequence Requirements for Binding of Src Family Tyrosine Kinases To Activated Growth Factor Receptors.J. Biol. Chem.270(17), 9840-9848.
Carlberg, K., Tapley, P., Haystead, C. Rohrschneider, L. (1991).The role kinase activity and the kinase insert region in ligand-induced internalization and degradation of the c-fmsprotein. Eur. Mol. Biol. Org. J. 10(4), 877-883.
Coussens, L., Van Beveren, C., Smith, D., Chen, E., Mitchell, R. L., Isacke, C. M., Verma, I. M., Ullrich, A. (1986). Structural alteration of viral homologue of receptor proto-oncogenefmsat carboxyl terminus.Nature320, 277-280.
Cox, S., Radzio-Andzelm, E. Taylor, S. S. (1994). Domain movements in protein kinases.Curr. Opin. Struct. Biol.4, 893-901.
Hanks, S. J., Quinn, A. M., Hunter, T. (1988). The Protein Kinase Family: Conserved Features and Deduced Phyogeny of the Catalytic Domains.Science241, 42-52.
Heidaran, et al, Aaronson, S. A. (1991). Deletion or Substitution within the α Platelet-Derived Growth Factor Receptor Kinase Insert Domain: Effects on Functional Coupling with Intracellular Signaling Pathways.Mol. Cell. Biol.11(1), 134-142.
Hubbard, S. R., Wei, L., Ellis, L. Hendrickson, W. A. (1994). Crystal structure of the tyrosine kinase domain of the human insulin receptor.Nature372,746-754.
Hubbard, S. R. (1997). Crystal structure on the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog.EMBO J.16(18), 5572-5581.
Johnson, L. N., Noble, M. E. M., Owen, D. J. (1996). Active and Inactive Protein Kinases: Structural Basis for Regulation.Cell85, 149-158.
Knighton, D. R., et al., Sowadski, J. M. (1991). Crystal Structure of the Catalytic Subunit of Cyclic Adenosine Monophosphate-Dependent Protein Kinase.Science253, 407-414.
McTigue, M. A., et al., Appelt, K. (1999). Crystal structure of the kinase domain of human vascular endothelial growth factor receptor 2: a key enzyme in angiogenesis.Structure7(3), 319-330.
Mohammadi, M., Schlessinger, J., Hubbard, S. R. (1996). Structure of the FGF Receptor Tyrosine Kinase Domain Reveals a Novel Autoinhibitory Mechanism.Cell86, 577-587.
Myles, G. M, Brandt, C. S., Carlsberg, K., Rohrschneider, L. R. (1994). Tyrosine 569 in thec-Fms Juxtamembrane Domain Is Essential for Kinase Activity and Macrophage Colony-Stimulating Factor-Dependent Internalization.Mol. Cell Biol.14(7), 4843-4854.
Pawson, T. (1992). Tyr721 regulates specific binding of the CSF-1 receptor kinase insert to PI 3′-kinase SH2 domains: a model for SH2-mediated receptor—target interactions.EMBO J.11(4), 1365-1372.
Roussel, M. F., Shurtleff, S. A., Downing, J. R., Sherr, C. J. (1990). A point mutation at tyrosine-809 in the human colony-stimulating factor 1 receptor impairs mitogenesis without abrogating tyrosine kinase activity, association with phosphatidylinositol 3-kinase, or induction ofc-fosandjunBgenes.Proc. Natl. Acad. Sci. USA87, 6738-6742.
Schindler, T., Bornmann, W., Pellicena, P., Miller, W. T., Clarkson, B., Kuriyan, J. (2000). Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase.Science289, 1938-1942.
Sengupta, A., Liu, W.-K., Yeung, Y. G., Yeung, D. C. Y., Frackelton, Jr., A. R., Stanley, E. R. (1988). Identification and subcellular localization of proteins that are rapidly phosphorylated in tyrosine in response to colony-stimulating factor-1.Proc. Natl. Acad. Sci. USA85, 8062-8066.
Sherr, C. J. (1988). Thefmsoncogene.Biochim. Biophys. Acta948, 225-243.
Sherr, C. J. (1991). Mitogenic response to colony-stimulating factor 1.Trends Genet.7(11-12), 398-402.
Shewchuk, L. M., et al, Moore, J. T. (2000). Structure of the Tie2 RTK Domain: Self-Inhibition by the Nucleotide Binding Loop, Activation Loop and C-Terminal Tail.Structure8, 1105-1113.
Taylor, G. R., Reedijk, M., Rothwell, V., Rohrschneider, L., Pawson, T. (1989). The unique insert of cellular and viralfmsprotein tyrosine kinase domains is dispensable for enzymatic and transforming activities.EMBO J.8(7), 2029-2037.
van der Geer, P. and Hunter, T. (1991). Tyrosine 706 and 807 Phosphorylation Site Mutants in the Murine Colony-Stimulating Factor-1 Receptor Are Unaffected in Their Ability To Bind or Phosphorylate Phosphatidylinositol-3 Kinase but Show Differential Defects in Their Ability To Induce Early Response Gene TranscriptionMol. Cell. Biol.11(9), 4698-4709.
Wang, Z., Myles, G. M., Brandt., C S., Lioubin, M. N., Rohrschneider, L. (1993). Identification of the Ligand-Binding Regions in the Macrophage Colony-Stimulating Factor Receptor Extracellular Domain.Mol. Cell. Biol.13(9), 5348-5359.
Chamberlain Stanley Dawes
Emerson Holly Kathleen
Musso David Lee
Peckham Gregory Edward
Coulter Kathryn L.
Rao Deepak
SmithKline Beecham Corporation
LandOfFree
Crystal structure of liganded cFMS kinase domain does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystal structure of liganded cFMS kinase domain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystal structure of liganded cFMS kinase domain will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4116153